Exactech Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Exactech's estimated annual revenue is currently $488.3M per year.(i)
  • Exactech received $40.0M in venture funding in June 2008.
  • Exactech's estimated revenue per employee is $401,600

Employee Data

  • Exactech has 1216 Employees.(i)
  • Exactech grew their employee count by 0% last year.

Exactech's People

NameTitleEmail/Phone
1
Co-Founder & EVP R&D (Emeritus)Reveal Email/Phone
2
Regional VP SalesReveal Email/Phone
3
CIOReveal Email/Phone
4
VP US SalesReveal Email/Phone
5
SVP, Engineering, Regulatory, Quality and Clinical AffairsReveal Email/Phone
6
VP Sales | WESTReveal Email/Phone
7
VP, Human ResourcesReveal Email/Phone
8
VP Global Finance and Corporate ControllerReveal Email/Phone
9
Vice Chair Board DirectorsReveal Email/Phone
10
VP AdministrationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.2M1128%N/AN/A
Add Company

What Is Exactech?

Exactech develops and produces bone and joint restoration products that help surgeons worldwide make patients more mobile. Since 1985, Exactech has looked at clinical challenges through the eyes of a surgeon, because it was founded by one. With global headquarters in Gainesville, Fla., Exactech distributes in more than 30 markets. Thanks for being a member of our community. Here a few guidelines to make your experience engaging, beneficial and excellent for everyone. We are a respectful community Exactech exists to help people improve their quality of life and regain their independence if they've been injured or developed arthritic disease. We strive to manage this community the same way we operate our business with a commitment to our values of Integrity, Compassion, Teamwork, Excellence and Innovation and we all have to do our part to respect fellow community members. Therefore, any comment or post that includes profanity, hate speech, personal attacks, false or misleading information, off-topic information, off-label claims, political endorsements, spam or third-party solicitations, or violates any of LinkedIn's Terms and Conditions will be removed. Duplicate posts may also be removed from our page. Posts may be removed at any time and at our discretion. Users who engage in prohibited conduct may be blocked from posting in our community without prior notice. We listen, we care You'll find that our page is operated by a team of specialists who are dedicated to helping you with your concerns, questions and general feedback. We reserve the right to refrain from commenting on the actions of our employees and partners. Sometimes we may need to take the conversation offline to be handled by the proper team. In these cases, we will need to share your contact information with various departments for a follow-up. You can see our privacy statement at https://www.exac.com/privacy-statement/.  

keywords:Biotechnology,Healthcare,Medical Devices,Pharmaceuticals

N/A

Total Funding

1216

Number of Employees

$488.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Exactech News

2022-04-19 - Exactech Knee and Ankle Replacement Implants Recall Lawsuits

A Simple Guide to Exactech Hip, Knee and Ankle Replacement Lawsuits and Settlements. Friday, April 22, 2022. How Do I Know If I Have a Exactech Claim?

2022-04-17 - Bradshaw and Bryant-Exactech Recall

There is a recall on the Exactech knee, ankle, and hip replacements. The defects contained within these devices can lead to several severe...

2022-03-30 - Exactech Lawsuits | Hip, Knee and Ankle Replacements Claims

Exactech replacement lawsuits seek compensation for injuries potentially caused by defective inserts and liners in Exactech knee, ankle and...

2018-02-15 - TPG Capital Completes Take-private Exactech Acquisition

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the successful completion of the previously announced merger agreement with TPG C ...

2017-12-04 - TPG Capital and Exactech Amend Deal Terms

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has entered into an amendment to its merger agreement with TPG Capital and certa ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$272M1388N/AN/A
#2
$354.3M1406N/AN/A
#3
$516.6M1757N/AN/A
#4
$582.6M2312N/AN/A
#5
$2192M57996%N/A

Exactech Funding

DateAmountRoundLead InvestorsReference
2008-06-17$40.0MUndisclosedSunTrust BankArticle